NCT00387582 - Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Diabetic RetinopathyDiabetic Macular Edema

Interventions

DRUG

Ranibizumab (Lucentis)

Lucentis 0.5 mg monthly for the first three months and then per protocol for the duration of the trial.

PROCEDURE

Argon Laser

Argon laser at entry to trial and then per protocol for the duration of the study.

Trial Locations (1)

Rocky Mountain Retina Consultants, Salt Lake City